4.6 out of 5 stars
(45816 Ratings)
IONOS offers GPU Servers that deliver a high-performance computing framework aimed at managing tasks that demand significantly more power than standard CPU systems can provide. This infrastructure features top-tier NVIDIA GPUs, including the H100, H200, and L40s, in addition to specialized AI accelerators like Intel Gaudi, facilitating extensive parallel processing for demanding applications. By utilizing GPU-accelerated instances, the cloud infrastructure is enhanced with dedicated graphical processors, enabling virtual machines to execute intricate calculations and handle data-heavy tasks at a much faster rate compared to traditional servers. This solution is especially well-suited for fields such as artificial intelligence, deep learning, and data science, where training models on extensive datasets or executing rapid inference processes is necessary. Furthermore, it accommodates big data analytics, scientific simulations, and visualization tasks, including 3D rendering or modeling, that necessitate substantial computational capacity. As a result, organizations seeking to optimize their processing capabilities for complex workloads can greatly benefit from this advanced infrastructure.
Learn more about IONOS Cloud GPU Servers
4.8 out of 5 stars
(139 Ratings)
Tractian is the Industrial Copilot for maintenance and reliability, combining hardware and software solutions to monitor asset performance, manage industrial operations, and implement predictive maintenance strategies. Its AI-driven platform empowers businesses to prevent unplanned equipment downtime and boost production output. The company is headquartered in Atlanta, GA, and extends its presence globally with offices in Mexico City and Sao Paulo. Learn more at tractian.com.
Learn more about TRACTIAN
Boltzmann AI Discovery Suite
The Boltzmann AI Discovery Suite is an online computational research platform created by Boltzmann Labs, tailored for teams in pharmaceuticals, biotechnology, and scientific research and development. This suite integrates a variety of tools that facilitate small-molecule design and screening, molecular docking, property prediction, and protein and antibody engineering, in addition to enzyme and peptide design, RNA and DNA design, synthetic chemistry, and molecular simulations. With this platform, researchers can effectively generate and assess potential molecules, anticipate molecular characteristics, investigate protein structures, devise retrosynthetic pathways, and execute computational workflows across various discovery endeavors. Furthermore, the suite promotes API access and compatibility with laboratory information management systems (LIMS), enhancing the synergy between computational research and laboratory processes. Users can choose from different plans, including a complimentary option and paid plans based on credits, allowing for tailored access to the platform's diverse capabilities. This flexibility ensures that both small teams and larger research groups can find a suitable plan that meets their specific research needs.
Learn more about Boltzmann AI Discovery Suite
BIOVIA Discovery Studio
The biopharmaceutical sector today is characterized by its intricacy, driven by increasing demands for enhanced specificity and safety, the emergence of new treatment classes, and the complexity of disease mechanisms. To navigate this intricate landscape, a profound comprehension of therapeutic dynamics is essential. Advanced modeling and simulation techniques offer a distinctive approach to investigate biological and physicochemical phenomena at the atomic scale. This methodology not only informs physical experimentation but also expedites the drug discovery and development phases. BIOVIA Discovery Studio integrates more than three decades of peer-reviewed research with cutting-edge in silico methodologies, including molecular mechanics, free energy assessments, and biotherapeutics developability, all within a unified framework. By equipping researchers with a comprehensive suite of tools, it facilitates a deeper examination of protein chemistry, thereby accelerating the discovery of both small and large molecule therapeutics, from Target Identification all the way through to Lead Optimization. Ultimately, this synergy of research and technology underscores the vital role of innovative tools in transforming biopharmaceutical advancements.
Learn more about BIOVIA Discovery Studio